Menopausal hormone therapy reduces risk of low bone mineral density by 69%, retrospective study finds

Article excerpt

Women taking menopausal hormone therapy cut their risk of low bone mineral density by 69%, according to a retrospective study presented at the Endocrine Society's annual meeting in Chicago. The finding adds to a growing body of evidence about hormone therapy's protective effects on bone health during and after menopause, when declining estrogen levels accelerate bone loss. Researchers compared women on hormone therapy with those who weren't using it, tracking bone mineral density measurements. The result suggests that for some women navigating menopause, hormone replacement may offer meaningful protection against osteoporosis and fracture risk.